Literature DB >> 12120264

Natural course of chronic pancreatitis.

P G Lankisch1.   

Abstract

Although the three leading symptoms of chronic pancreatitis, pain, exocrine and endocrine pancreatic insufficiency, are well known, only a few long-term studies have correlated these symptoms with the natural course of the disease. Besides these symptoms, numerous pancreatic complications and/or pancreatitis-associated diseases may affect the course and determine the prognosis of chronic pancreatitis. Their influence, however, has not been studied in detail. This review has two major aims: The first one is to give an up-to-date survey of present knowledge on the natural course of the disease with a view to the leading symptoms under special consideration of how the duration of the disease, continual alcohol abuse as well as endoscopic procedures and surgical treatment affect pain. Included is also what is known about chronic pancreatitis as a precondition of pancreatic and extrapancreatic carcinoma. The effect of chronic pancreatitis on the socio-economic status of patients is discussed and the mortality rate of the disease. The second aim of this review is to stimulate pancreatologists from different centers to consolidate resources in order to perform larger controlled studies than any one single center can undertake and work out common criteria for the diagnosis of chronic pancreatitis and follow-up of its course.

Entities:  

Mesh:

Year:  2001        PMID: 12120264     DOI: 10.1159/000055786

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  33 in total

1.  Endoscopic ultrasound-guided celiac plexus neurolysis.

Authors:  Assaad M Soweid; Cecilio Azar
Journal:  World J Gastrointest Endosc       Date:  2010-06-16

2.  Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans.

Authors:  J J Meier; T G K Breuer; R C Bonadonna; A Tannapfel; W Uhl; W E Schmidt; H Schrader; B A Menge
Journal:  Diabetologia       Date:  2012-05       Impact factor: 10.122

Review 3.  Symposium 3. Chronic pancreatitis: current problems of the diagnostic criteria.

Authors:  Makoto Otsuki
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 4.  Do the diagnostic criteria differ between alcoholic and nonalcoholic chronic pancreatitis?

Authors:  Rudolf W Ammann; Beat Mullhaupt
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 5.  Role of endosonography in non-malignant pancreatic diseases.

Authors:  Kyung W Noh; Surakit Pungpapong; Massimo Raimondo
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

6.  Antioxidants for pain relief in chronic pancreatitis.

Authors:  Jens Werner; Markus W Büchler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

Review 7.  Postoperative care following pancreatic surgery: surveillance and treatment.

Authors:  Volker Keim; Ernst Klar; Michael Poll; Michael H Schoenberg
Journal:  Dtsch Arztebl Int       Date:  2009-11-27       Impact factor: 5.594

8.  Quality of life in patients after pancreaticoduodenectomy for chronic pancreatitis.

Authors:  Felix Rückert; Marius Distler; Sven Hoffmann; Doreen Hoffmann; Christian Pilarsky; Frank Dobrowolski; Hans-Detlev Saeger; Robert Grützmann
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

9.  Effects of sensory denervation by neonatal capsaicin administration on experimental pancreatitis induced by dibutyltin dichloride.

Authors:  Tsukasa Ikeura; Yosky Kataoka; Taketoshi Wakabayashi; Tetsuji Mori; Yasuharu Takamori; Shoichiroh Takamido; Kazuichi Okazaki; Hisao Yamada
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

10.  Establishment and characterization of a rat pancreatic stellate cell line by spontaneous immortalization.

Authors:  Atsushi Masamune; Masahiro Satoh; Kazuhiro Kikuta; Noriaki Suzuki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.